91.5%
disease-modifying therapyFabry disease68Ga-DOTATATEFabry cardiomyopathy
…R 57–70) years; 58% male; 50% classical phenotype. All received disease-modifying therapy. Focal 68Ga-DOTATATE uptake was present in all patients with he…
7,227articles mentioning treatments
16,644treatment mentions
4,719distinct treatments extracted
0%of mentions human-reviewed
All extracted treatments
Showing 541–600 of 4,719, ordered by supporting articles. Choose a treatment to see its evidence.
Locoregional therapy3Pancreatic Enzyme Replacement Therapy3Peroral endoscopic myotomy3Pharmacologic treatment3Positive Airway Pressure (PAP) therapy3Regional analgesia3Traditional Chinese Medicine3Vitamin supplementation3advanced therapies3anti-PD1 therapy3anti-VEGF therapy3anti-programmed cell death protein-1 therapy3antiarrhythmic therapy3anticancer therapies3anticancer therapy3autologous stem cell transplantation3behavioural therapy3cancer therapies3chimeric antigen receptor T-cell therapy3clinical management3cognitive–behavioural therapy3conventional immunosuppression3coronary revascularisation3deworming3diabetes treatment3dopaminergic therapy3haematopoietic stem cell transplantation3immunotherapy treatment3inhaled corticosteroids3intensive care treatment3intravenous fluid therapy3intravenous iron therapy3lethal palliation3lifestyle changes3local anaesthesia3neurocritical care3novel therapies3nutritional support3occupational therapy3oral antibiotics3outpatient treatment3palliative chemotherapy3pharmacological interventions3physical rehabilitation3preventive measures3standard therapy3standard treatment3stent retriever thrombectomy3supportive treatment3surgical interventions3surgical management3symptomatic therapy3targeted treatment3topical therapy3tracheostomy3tyrosine kinase inhibitors3ultrasound-guided nerve blocks3vasodilator therapy3vasopressors3ventriculoperitoneal shunting3
Articles mentioning treatments
7,227 articles · page 306 of 603revascularisationCoronary artery diseasemyocardial infarctionHoltackers et al
…iac events. Furthermore, regional functional recovery following revascularisation is shown to be highly dependent on infarct transmurality, and s…
disease-modifying treatmentmultiple sclerosisMSSpanish neuroimmunology centresAMH
…-up 6.5 years (0.01–29.4) and AMH 2.2 (0.01–17.4); 68% received disease-modifying treatment. AMH levels did not differ between patients and controls and we…
mechanical ventilationDiaphragm dysfunctionNCT07256821Wales Research Ethics Committee 4
…n Diaphragm dysfunction is associated with failure to wean from mechanical ventilation. Inspiratory muscle training (IMT) may help improve outcomes fo…
Auricular vagal neuromodulation therapyHospital Anxiety and Depression ScaleMedical University of ViennaPostural orthostatic tachycardia syndrome (POTS)POTS
…ed relief and do not sufficiently address non-cardiac symptoms. Auricular vagal neuromodulation therapy (AVNT) and slow-paced diaphragmatic breathing (SDB) have each d…
targeted therapiesSjDSjögren’s disease (SjD)
…l dysregulation. These insights have fuelled the development of targeted therapies designed to modulate specific immune pathways, aiming to interr…
electroconvulsive therapy
…team work together to manage the anxiety she experiences during electroconvulsive therapy…
second-line treatmentsICIparaneoplastic phenotypesnational reference center
… first-line treatments, and 33/163 patients (20%) also received second-line treatments. Early neurological recovery was observed in 82/164 patients (5…
treatment-as-usualalcohol-related diseasesDAIs
…ual cohorts: one receiving a DAI cohort and the other receiving treatment-as-usual (TAU cohort). We contrasted incidence rates for ten alcohol-rel…
maintenance therapyrituximabgranulomatosis with polyangiitisGPA
…or relapse, hospitalisation and damage accumulation risk during maintenance therapy in anti-neutrophil cytoplasmic antibody (ANCA)-associated vascu…
Patient experiences of idiopathic pulmonary fibrosis (IPF) in China: a multicentre qualitative study
pharmacological therapiesIdiopathic pulmonary fibrosis (IPF)
…ng disease that profoundly impacts patients’ daily lives. While pharmacological therapies continue to advance, less is known about how patients experienc…
physiotherapySpinal muscular atrophy (SMA)
…n particular, gaps were noted in access to respiratory support, physiotherapy and nutritional management. These findings suggest that the app…